Maxcyte (MXCT) Shares Outstanding (Diluted) (2020 - 2026)
Maxcyte (MXCT) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 106.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.82 Mn |
| Mar 31, 2026 | 106.88 Mn |
| Dec 31, 2025 | 106.43 Mn |
| Sep 30, 2025 | 106.61 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | 105.95 Mn |
| Dec 31, 2024 | 104.85 Mn |
| Sep 30, 2024 | 105.11 Mn |
| Jun 30, 2024 | 104.64 Mn |
| Mar 31, 2024 | 104.09 Mn |
| Dec 31, 2023 | 103.27 Mn |
| Sep 30, 2023 | 103.45 Mn |
| Jun 30, 2023 | 103.06 Mn |
| Mar 31, 2023 | 102.85 Mn |
| Dec 31, 2022 | 101.70 Mn |
| Sep 30, 2022 | 101.81 Mn |
| Jun 30, 2022 | 101.43 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 90.62 Mn |
| Sep 30, 2021 | 84.71 Mn |